461 related articles for article (PubMed ID: 27569031)
1. Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models.
Sarisozen C; Dhokai S; Tsikudo EG; Luther E; Rachman IM; Torchilin VP
Eur J Pharm Biopharm; 2016 Nov; 108():54-67. PubMed ID: 27569031
[TBL] [Abstract][Full Text] [Related]
2. Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin.
Abouzeid AH; Patel NR; Rachman IM; Senn S; Torchilin VP
J Drug Target; 2013 Dec; 21(10):994-1000. PubMed ID: 24098980
[TBL] [Abstract][Full Text] [Related]
3. Glucose transporter 1-mediated vascular translocation of nanomedicines enhances accumulation and efficacy in solid tumors.
Suzuki K; Miura Y; Mochida Y; Miyazaki T; Toh K; Anraku Y; Melo V; Liu X; Ishii T; Nagano O; Saya H; Cabral H; Kataoka K
J Control Release; 2019 May; 301():28-41. PubMed ID: 30844476
[TBL] [Abstract][Full Text] [Related]
4. The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.
Sarisozen C; Abouzeid AH; Torchilin VP
Eur J Pharm Biopharm; 2014 Oct; 88(2):539-50. PubMed ID: 25016976
[TBL] [Abstract][Full Text] [Related]
5. Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles.
Wang J; Ma W; Tu P
Macromol Biosci; 2015 Sep; 15(9):1252-61. PubMed ID: 25981672
[TBL] [Abstract][Full Text] [Related]
6. Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer.
Scarano W; de Souza P; Stenzel MH
Biomater Sci; 2015 Jan; 3(1):163-74. PubMed ID: 26214199
[TBL] [Abstract][Full Text] [Related]
7. Enhanced targeting of 3D pancreatic cancer spheroids by aptamer-conjugated polymeric micelles with deep tumor penetration.
Tian L; Pei R; Zhong L; Ji Y; Zhou D; Zhou S
Eur J Pharmacol; 2021 Mar; 894():173814. PubMed ID: 33352182
[TBL] [Abstract][Full Text] [Related]
8. Cell microenvironment-controlled antitumor drug releasing-nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy.
Guo Y; Zhang Y; Li J; Zhang Y; Lu Y; Jiang X; He X; Ma H; An S; Jiang C
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5444-53. PubMed ID: 25686400
[TBL] [Abstract][Full Text] [Related]
9. Transferrin-Modified Vitamin-E/Lipid Based Polymeric Micelles for Improved Tumor Targeting and Anticancer Effect of Curcumin.
Muddineti OS; Kumari P; Ghosh B; Biswas S
Pharm Res; 2018 Mar; 35(5):97. PubMed ID: 29541866
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin and lapatinib combination nanomedicine for treating resistant breast cancer.
Wang H; Li F; Du C; Wang H; Mahato RI; Huang Y
Mol Pharm; 2014 Aug; 11(8):2600-11. PubMed ID: 24405470
[TBL] [Abstract][Full Text] [Related]
12. Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.
Perche F; Patel NR; Torchilin VP
J Control Release; 2012 Nov; 164(1):95-102. PubMed ID: 22974689
[TBL] [Abstract][Full Text] [Related]
13. Micelle-assisted combination therapies for effective glioblastoma treatment: an in-vitro assessment.
Mohanty AK; Mohanta GP
Anticancer Drugs; 2015 Mar; 26(3):312-22. PubMed ID: 25462134
[TBL] [Abstract][Full Text] [Related]
14. Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells.
Abouzeid AH; Patel NR; Sarisozen C; Torchilin VP
Pharm Res; 2014 Aug; 31(8):1938-45. PubMed ID: 24522815
[TBL] [Abstract][Full Text] [Related]
15. Polymeric micellar co-delivery of resveratrol and curcumin to mitigate in vitro doxorubicin-induced cardiotoxicity.
Carlson LJ; Cote B; Alani AW; Rao DA
J Pharm Sci; 2014 Aug; 103(8):2315-22. PubMed ID: 24914015
[TBL] [Abstract][Full Text] [Related]
16. On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier.
Li H; Li M; Chen C; Fan A; Kong D; Wang Z; Zhao Y
Int J Pharm; 2015 Nov; 495(1):572-578. PubMed ID: 26387617
[TBL] [Abstract][Full Text] [Related]
17. Combination of magnetic targeting with synergistic inhibition of NF-κB and glutathione via micellar drug nanomedicine enhances its anti-tumor efficacy.
Elhasany KA; Khattab SN; Bekhit AA; Ragab DM; Abdulkader MA; Zaky A; Helmy MW; Ashour HMA; Teleb M; Haiba NS; Elzoghby AO
Eur J Pharm Biopharm; 2020 Oct; 155():162-176. PubMed ID: 32818610
[TBL] [Abstract][Full Text] [Related]
18. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional redox-responsive and CD44 receptor targeting polymer-drug nanomedicine based curcumin and alendronate: synthesis, characterization and in vitro evaluation.
Dong X; Zou S; Guo C; Wang K; Zhao F; Fan H; Yin J; Chen D
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):168-177. PubMed ID: 29239219
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance.
Wang F; Zhang D; Zhang Q; Chen Y; Zheng D; Hao L; Duan C; Jia L; Liu G; Liu Y
Biomaterials; 2011 Dec; 32(35):9444-56. PubMed ID: 21903258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]